{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:34:42Z","timestamp":1773358482817,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.cld.2012.03.010","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T04:22:02Z","timestamp":1335327722000},"page":"331-346","source":"Crossref","is-referenced-by-count":59,"title":["Pruritus in Chronic Cholestatic Liver Disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Chalermrat","family":"Bunchorntavakul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cld.2007.11.009","article-title":"Update on the treatment of the pruritus of cholestasis","volume":"12","author":"Bergasa","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2012.03.010_bib2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1023\/A:1018865809556","article-title":"Pruritus in chronic hepatitis C: association with high serum bile acids, advanced pathology, and bile duct abnormalities","volume":"42","author":"Lebovics","year":"1997","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib3","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/hep.20704","article-title":"AASLD practice guidelines: evaluation of the patient for liver transplantation","volume":"41","author":"Murray","year":"2005","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2012.03.010_bib4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2036.2003.01458.x","article-title":"Review article: pruritus in cholestatic and other liver diseases","volume":"17","author":"Mela","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2340\/00015555-0350","article-title":"Itch in primary biliary cirrhosis: a patients' perspective","volume":"88","author":"Rishe","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.cld.2012.03.010_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2012.03.010_bib8","first-page":"1258","article-title":"Pruritus and jaundice","volume":"92","author":"McPhedran","year":"1965","journal-title":"Can Med Assoc J"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clinre.2010.10.007","article-title":"Pathophysiology and current management of pruritus in liver disease","volume":"35","author":"Kremer","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2012.03.010_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2346.2000.00727.x","article-title":"Itching after intrathecal morphine. Incidence and treatment","volume":"17","author":"Slappendel","year":"2000","journal-title":"Eur J Anaesthesiol"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib12","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jhep.2005.09.004","article-title":"The pruritus of cholestasis","volume":"43","author":"Bergasa","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2012.03.010_bib13","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0016-5085(19)31870-0","article-title":"Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus","volume":"73","author":"Ghent","year":"1977","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2012.03.010_bib14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/archderm.1974.01630050024005","article-title":"Pruritus induced by crude bile and purified bile acids. Experimental production of pruritus in human skin","volume":"109","author":"Varadi","year":"1974","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1023\/A:1018868126743","article-title":"Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis","volume":"43","author":"Ricci","year":"1998","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.cld.2012.03.010_bib16","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.23821","article-title":"The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Kuiper","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2012.03.010_bib17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.1840110526","article-title":"The pruritus of cholestasis: from bile acids to opiate agonists","volume":"11","author":"Jones","year":"1990","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-8278(05)80471-4","article-title":"Cholestasis in the male rat is associated with naloxone-reversible antinociception","volume":"20","author":"Bergasa","year":"1994","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0016-5085(92)90857-U","article-title":"Endogenous opioids accumulate in plasma in a rat model of acute cholestasis","volume":"103","author":"Swain","year":"1992","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"10.1016\/j.cld.2012.03.010_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0168-8278(92)90040-V","article-title":"Central mu-opioid receptors are down-regulated in a rat model of cholestasis","volume":"15","author":"Bergasa","year":"1992","journal-title":"J\u00a0Hepatol"},{"issue":"6658","key":"10.1016\/j.cld.2012.03.010_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/bmj.297.6658.1241","article-title":"Plasma methionine enkephalin concentration and prognosis in primary biliary cirrhosis","volume":"297","author":"Thornton","year":"1988","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jhep.2005.11.043","article-title":"Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated","volume":"44","author":"Nelson","year":"2006","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","article-title":"Lysophosphatidic acid is a potential mediator of cholestatic pruritus","volume":"139","author":"Kremer","year":"2010","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.cld.2012.03.010_bib24","first-page":"2028","article-title":"Methionine-enkephalin concentrations correlate with stage of disease but not pruritus in patients with primary biliary cirrhosis","volume":"89","author":"Spivey","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000056338","article-title":"Scratching behavior in various strains of mice","volume":"14","author":"Inagaki","year":"2001","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000211009","article-title":"Peripheral and central mediators of itch","volume":"5","author":"Hagermark","year":"1992","journal-title":"Skin Pharmacol"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1213\/ane.0b013e3181a45a6b","article-title":"Serotonin receptor antagonists for the prevention and treatment of pruritus, nausea, and vomiting in women undergoing cesarean delivery with intrathecal morphine: a systematic review and meta-analysis","volume":"109","author":"George","year":"2009","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.plipres.2007.02.001","article-title":"Regulation and biological activities of the autotaxin-LPA axis","volume":"46","author":"van Meeteren","year":"2007","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000078632","article-title":"Itch-scratch responses induced by lysophosphatidic acid in mice","volume":"72","author":"Hashimoto","year":"2004","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1089-3261(03)00135-1","article-title":"Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease","volume":"8","author":"Paumgartner","year":"2004","journal-title":"Clin Liver Dis"},{"issue":"17","key":"10.1016\/j.cld.2012.03.010_bib31","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3748\/wjg.15.2049","article-title":"Intrahepatic cholestasis of pregnancy","volume":"15","author":"Geenes","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2012.03.010_bib32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group","volume":"336","author":"Lindor","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2012.03.010_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1542-3565(03)00134-4","article-title":"Natural history of pruritus in primary biliary cirrhosis","volume":"1","author":"Talwalkar","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2012.03.010_bib35","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0016-5085(99)70403-8","article-title":"A\u00a0prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis","volume":"117","author":"Kaplan","year":"1999","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib36","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A\u00a0controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"J\u00a0Hepatol"},{"issue":"20","key":"10.1016\/j.cld.2012.03.010_bib37","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A\u00a0controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib38","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/gast.1999.0029900400","article-title":"Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial","volume":"117","author":"Hendrickse","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2012.03.010_bib39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.1961.03040180034008","article-title":"Relief of the pruritus of jaundice with a bile-acid sequestering resin","volume":"176","author":"Carey","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2012.03.010_bib40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM196109072651004","article-title":"The treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramine","volume":"265","author":"Van Itallie","year":"1961","journal-title":"N\u00a0Engl J Med"},{"issue":"5325","key":"10.1016\/j.cld.2012.03.010_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/bmj.1.5325.216","article-title":"Treatment of pruritus of obstructive jaundice with cholestyramine","volume":"1","author":"Datta","year":"1963","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0016-5085(66)80071-9","article-title":"Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis","volume":"50","author":"Datta","year":"1966","journal-title":"Gastroenterology"},{"issue":"5058","key":"10.1016\/j.cld.2012.03.010_bib43","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.1589765","article-title":"Cholecystokinin antianalgesia: safety cues abolish morphine analgesia","volume":"256","author":"Wiertelak","year":"1992","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.cld.2012.03.010_bib44","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJM197406062902326","article-title":"Letter: timing of cholestyramine doses in cholestatic liver disease","volume":"290","author":"Javitt","year":"1974","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2362.2000.00606.x","article-title":"Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man","volume":"30","author":"Rust","year":"2000","journal-title":"Eur J Clin Invest"},{"issue":"7-8","key":"10.1016\/j.cld.2012.03.010_bib46","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1345\/aph.10263","article-title":"Colesevelam hydrochloride: a novel bile acid-binding resin","volume":"35","author":"Aldridge","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/gut.26.3.291","article-title":"Role of plasmapheresis in primary biliary cirrhosis","volume":"26","author":"Cohen","year":"1985","journal-title":"Gut"},{"key":"10.1016\/j.cld.2012.03.010_bib48","first-page":"233","article-title":"Therapeutic plasmapheresis for cholestatic liver diseases: study of 9 cases","volume":"337","author":"Omokawa","year":"1990","journal-title":"Prog Clin Biol Res"},{"issue":"8","key":"10.1016\/j.cld.2012.03.010_bib49","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.transproceed.2006.08.052","article-title":"Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS)","volume":"38","author":"Montero","year":"2006","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib50","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1572-0241.2004.30204.x","article-title":"Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis","volume":"99","author":"Pares","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jhep.2010.02.031","article-title":"Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers","volume":"53","author":"Pares","year":"2010","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib52","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jca.2920020303","article-title":"The clinical effectiveness and safety of chronic plasmapheresis in patients with primary biliary cirrhosis","volume":"2","author":"Ambinder","year":"1985","journal-title":"J\u00a0Clin Apher"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/lt.20001","article-title":"Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis","volume":"10","author":"Bellmann","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2012.03.010_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-0711-5-3","article-title":"Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor","volume":"5","author":"Chen","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib55","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"issue":"8638","key":"10.1016\/j.cld.2012.03.010_bib56","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0140-6736(89)91608-5","article-title":"Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis","volume":"1","author":"Bachs","year":"1989","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib57","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7326\/0003-4819-82-3-310","article-title":"Phenobarbital effects in cholestatic liver diseases","volume":"82","author":"Bloomer","year":"1975","journal-title":"Ann Intern Med"},{"issue":"20","key":"10.1016\/j.cld.2012.03.010_bib58","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJM197605132942008","article-title":"Rifampin-induced methadone withdrawal","volume":"294","author":"Kreek","year":"1976","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib59","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.21987","article-title":"Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine","volume":"47","author":"Glantz","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF01300759","article-title":"Treatment of pruritus of primary biliary cirrhosis with rifampin","volume":"36","author":"Podesta","year":"1991","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib61","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2012.03.010_bib62","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.cld.2012.03.010_bib63","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","article-title":"The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus","volume":"102","author":"Tandon","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib64","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.50.3.436","article-title":"Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis","volume":"50","author":"Prince","year":"2002","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cld.2012.03.010_bib65","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/hep.23534","article-title":"Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome","volume":"51","author":"Kumar","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2036.1994.tb00297.x","article-title":"Flumecinol for the treatment of pruritus associated with primary biliary cirrhosis","volume":"8","author":"Turner","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib67","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0016-5085(92)90102-5","article-title":"A\u00a0controlled trial of naloxone infusions for the pruritus of chronic cholestasis","volume":"102","author":"Bergasa","year":"1992","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.cld.2012.03.010_bib69","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","article-title":"Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study","volume":"113","author":"Wolfhagen","year":"1997","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib70","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.510270307","article-title":"Open-label trial of oral nalmefene therapy for the pruritus of cholestasis","volume":"27","author":"Bergasa","year":"1998","journal-title":"Hepatology"},{"issue":"3 Pt 1","key":"10.1016\/j.cld.2012.03.010_bib71","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(99)70117-9","article-title":"Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study","volume":"41","author":"Bergasa","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib72","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(02)00318-5","article-title":"Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study","volume":"37","author":"Terg","year":"2002","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2012.03.010_bib73","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3748\/wjg.v12.i7.1125","article-title":"Effect of oral naltrexone on pruritus in cholestatic patients","volume":"12","author":"Mansour-Ghanaei","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2012.03.010_bib74","first-page":"1022","article-title":"Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease","volume":"91","author":"Carson","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"6662","key":"10.1016\/j.cld.2012.03.010_bib75","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/bmj.297.6662.1501","article-title":"Opioid peptides and primary biliary cirrhosis","volume":"297","author":"Thornton","year":"1988","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib76","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0016-5085(00)70225-3","article-title":"Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis","volume":"118","author":"Jones","year":"2000","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib77","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.102.044909","article-title":"Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys","volume":"305","author":"Ko","year":"2003","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.cld.2012.03.010_bib78","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00042737-199810000-00010","article-title":"Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial","volume":"10","author":"Muller","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3959(94)00145-5","article-title":"Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron","volume":"61","author":"Schworer","year":"1995","journal-title":"Pain"},{"issue":"76","key":"10.1016\/j.cld.2012.03.010_bib80","first-page":"1196","article-title":"Ondansetron and pruritus in chronic liver disease: a controlled study","volume":"54","author":"Jones","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2012.03.010_bib81","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2036.2005.02430.x","article-title":"A\u00a0controlled trial of ondansetron in the pruritus of cholestasis","volume":"21","author":"O'Donohue","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.cld.2012.03.010_bib82","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/j.1572-0241.2003.08662.x","article-title":"Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis","volume":"98","author":"Browning","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib83","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2012.03.010_bib84","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21370","article-title":"Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial","volume":"44","author":"Bergasa","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib85","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1213\/ane.0b013e3181730130","article-title":"Preoperative gabapentin prevents intrathecal morphine-induced pruritus after orthopedic surgery","volume":"106","author":"Sheen","year":"2008","journal-title":"Anesth Analg"},{"issue":"7","key":"10.1016\/j.cld.2012.03.010_bib86","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1345\/aph.1L038","article-title":"Role of gabapentin in the treatment of uremic pruritus","volume":"42","author":"Vila","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.cld.2012.03.010_bib87","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.burns.2010.06.004","article-title":"A\u00a0comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus","volume":"37","author":"Ahuja","year":"2011","journal-title":"Burns"},{"issue":"21","key":"10.1016\/j.cld.2012.03.010_bib88","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1016\/S0024-3205(03)00668-4","article-title":"The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis","volume":"73","author":"Gingold","year":"2003","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.cld.2012.03.010_bib89","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1572-0241.2002.05852.x","article-title":"Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease","volume":"97","author":"Neff","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib90","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0016-5085(93)90858-A","article-title":"Subhypnotic doses of propofol relieve pruritus associated with liver disease","volume":"104","author":"Borgeat","year":"1993","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2012.03.010_bib91","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.amjmed.2005.05.031","article-title":"Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases","volume":"118","author":"Villamil","year":"2005","journal-title":"Am J Med"},{"issue":"7796","key":"10.1016\/j.cld.2012.03.010_bib92","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(73)90055-X","article-title":"Intravenous lignocaine for relief of intractable itch","volume":"1","author":"Watson","year":"1973","journal-title":"Lancet"},{"issue":"6628","key":"10.1016\/j.cld.2012.03.010_bib93","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/bmj.296.6628.1066-b","article-title":"Effect of stanozolol on itching in primary biliary cirrhosis","volume":"296","author":"Seymour","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"10.1016\/j.cld.2012.03.010_bib94","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.gastro.2005.06.019","article-title":"Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy","volume":"129","author":"Kondrackiene","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib95","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0168-8278(97)80146-8","article-title":"Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo","volume":"27","author":"Palma","year":"1997","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2012.03.010_bib96","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/JPM.2006.077","article-title":"Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of intrahepatic cholestasis of pregnancy","volume":"34","author":"Binder","year":"2006","journal-title":"J\u00a0Perinat Med"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib97","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1471-0528.2003.00029.x","article-title":"A\u00a0randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis","volume":"111","author":"Roncaglia","year":"2004","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib98","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0016-5085(90)91250-A","article-title":"Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study","volume":"99","author":"Frezza","year":"1990","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib99","first-page":"1084","article-title":"S-adenosyl-l-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results","volume":"13","author":"Ribalta","year":"1991","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2012.03.010_bib100","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.20952","article-title":"Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid","volume":"42","author":"Glantz","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2012.03.010_bib101","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bpg.2010.07.010","article-title":"Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy","volume":"24","author":"van der Woerd","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2012.03.010_bib102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.20998","article-title":"Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis","volume":"43","author":"Stapelbroek","year":"2006","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112000281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326112000281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T22:14:58Z","timestamp":1561673698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326112000281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1089326112000281"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2012.03.010","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}